Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas

Cancer Cell

Volumn 33, Issue 4, 2018, Pages 721-735.e8

  Liu, Yang ^a,b   Sethi, Nilay S ^a,b   Hinoue, Toshinori ^c   Schneider, Barbara G ^d   Cherniack, Andrew D ^a,b,s   Sanchez Vega, Francisco ^e   Seoane, Jose A ^f   Farshidfar, Farshad ^g   Bowlby, Reanne ^h   Islam, Mirazul ^a,b   Kim, Jaegil ^a   Chatila, Walid ^e,s   Akbani, Rehan ⁱ   Kanchi, Rupa S ⁱ   Rabkin, Charles S ^j   Willis, Joseph E ^k   Wang, Kenneth K ^l   McCall, Shannon J ^m,s   Mishra, Lopa ⁿ   Ojesina, Akinyemi I ^o,r   Bullman, Susan ^b   Pedamallu, Chandra Sekhar ^b   Lazar, Alexander J ^i,s   Sakai, Ryo ^p   Caesar Johnson, Samantha J ^s   Demchok, John A ^s   Felau, Ina ^s   Kasapi, Melpomeni ^s   Ferguson, Martin L ^s   Hutter, Carolyn M ^s   Sofia, Heidi J ^s   Tarnuzzer, Roy ^s   Wang, Zhining ^s   Yang, Liming ^s   Zenklusen, Jean C ^s   Laird, Peter W ^c   Thorsson, Vésteinn ^q   Bass, Adam J ^a,b   more..

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALGARY   (Canada)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

ⁱ UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

^k CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l MAYO CLINIC   (United States)

^m DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ GEORGE WASHINGTON UNIVERSITY   (United States)

^o UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^p PharmiWeb Solutions   (United Kingdom)

^q INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^r HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^s Julia)

more..

Author keywords

cancer; colon; colorectal; epigenetic; esophagus; genomic; methylation; rectum; stomach; tumor

Indexed keywords

5 METHYLCYTOSINE; APC PROTEIN; APOLIPOPROTEIN B MRNA EDITING ENZYME CATALYTIC POLYPEPTIDE LIKE; ATM PROTEIN; BIM PROTEIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CYCLIN DEPENDENT KINASE 6; DNA; F BOX/WD REPEAT CONTAINING PROTEIN 7; GAMMA INTERFERON; K RAS PROTEIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KRUPPEL LIKE FACTOR 4; KRUPPEL LIKE FACTOR 5; MESSENGER RNA; MICRORNA; MUTL PROTEIN HOMOLOG 1; PARTNER AND LOCALIZER OF BRCA2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR PCBP1; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; DNA DIRECTED DNA POLYMERASE ALPHA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; KRAS PROTEIN, HUMAN; MLH1 PROTEIN, HUMAN; PCBP1 PROTEIN, HUMAN; POLE PROTEIN, HUMAN; POLY ADP RIBOSE BINDING PROTEIN; PROTEIN P21; SOX9 PROTEIN, HUMAN;

ADULT; AGED; ANEUPLOIDY; ARTICLE; ASCENDING COLON; CANCER GENETICS; CHROMOSOMAL INSTABILITY; COLON ADENOCARCINOMA; CONTROLLED STUDY; CPG ISLAND; DEAMINATION; DESCENDING COLON; DNA METHYLATION; EPIGENETICS; ESOPHAGEAL ADENOCARCINOMA; FEMALE; FRAMESHIFT MUTATION; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE MUTATION; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL TOLERANCE; INDEL MUTATION; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MOLECULAR PATHOLOGY; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RECTUM CARCINOMA; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; STOMACH ADENOCARCINOMA; WHOLE EXOME SEQUENCING; ADENOCARCINOMA; CLASSIFICATION; COMPARATIVE STUDY; GASTROINTESTINAL TUMOR; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; MUTATION;

ADENOCARCINOMA; ANEUPLOIDY; CHROMOSOMAL INSTABILITY; DNA METHYLATION; DNA POLYMERASE II; EPIGENESIS, GENETIC; FEMALE; GASTROINTESTINAL NEOPLASMS; GENE REGULATORY NETWORKS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MALE; MICROSATELLITE INSTABILITY; MUTATION; MUTL PROTEIN HOMOLOG 1; POLY-ADP-RIBOSE BINDING PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS P21(RAS); SOX9 TRANSCRIPTION FACTOR;

EID: 85044904369     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2018.03.010     Document Type: Article

References (97)

1. Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Aparicio, S.A., Behjati, S., Biankin, A.V., Bignell, G.R., Bolli, N., Borg, A., Borresen-Dale, A.L., et al. Signatures of mutational processes in human cancer. Nature 500 (2013), 415–421.
2. Alexandrov, L.B., Nik-Zainal, S., Siu, H.C., Leung, S.Y., Stratton, M.R., A mutational signature in gastric cancer suggests therapeutic strategies. Nat. Commun., 6, 2015, 8683.
3. Arnold, M., Soerjomataram, I., Ferlay, J., Forman, D., Global incidence of oesophageal cancer by histological subtype in 2012. Gut 64 (2015), 381–387.
4. Banerjea, A., Hands, R.E., Powar, M.P., Bustin, S.A., Dorudi, S., Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence. Colorectal Dis. 11 (2009), 601–608.
5. Bignell, G.R., Greenman, C.D., Davies, H., Butler, A.P., Edkins, S., Andrews, J.M., Buck, G., Chen, L., Beare, D., Latimer, C., et al. Signatures of mutation and selection in the cancer genome. Nature 463 (2010), 893–898.
6. Bijlsma, M.F., Sadanandam, A., Tan, P., Vermeulen, L., Molecular subtypes in cancers of the gastrointestinal tract. Nat. Rev. Gastroenterol. Hepatol. 14 (2017), 333–342.
7. Bonhomme, C., Duluc, I., Martin, E., Chawengsaksophak, K., Chenard, M.P., Kedinger, M., Beck, F., Freund, J.N., Domon-Dell, C., The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut 52 (2003), 1465–1471.
8. Budinska, E., Popovici, V., Tejpar, S., D'Ario, G., Lapique, N., Sikora, K.O., Di Narzo, A.F., Yan, P., Hodgson, J.G., Weinrich, S., et al. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. J. Pathol. 231 (2013), 63–76.
9. Bunz, F., Fauth, C., Speicher, M.R., Dutriaux, A., Sedivy, J.M., Kinzler, K.W., Vogelstein, B., Lengauer, C., Targeted inactivation of p53 in human cells does not result in aneuploidy. Cancer Res. 62 (2002), 1129–1133.
10. Cancer Genome Atlas Research Network, Integrated genomic analyses of ovarian carcinoma. Nature 474 (2011), 609–615.
11. Cancer Genome Atlas Research Network, Comprehensive molecular characterization of human colon and rectal cancer. Nature 487 (2012), 330–337.
12. Cancer Genome Atlas Research Network, Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513 (2014), 202–209.
13. Cancer Genome Atlas Research Network, Integrated genomic characterization of oesophageal carcinoma. Nature 541 (2017), 169–175.
14. Carter, S.L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P.W., Onofrio, R.C., Winckler, W., Weir, B.A., et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30 (2012), 413–421.
15. Chakravarty, D., Gao, J., Phillips, S., Kundra, R., Zhang, H., Wang, J., Rudolph, J.E., Yaeger, R., Soumerai, T., Nissan, M.H., et al. OncoKB: a precision oncology knowledge base. JCO Precis. Oncol., 2017, 10.1200/PO.17.00011.
16. Chan, T.L., Curtis, L.C., Leung, S.Y., Farrington, S.M., Ho, J.W., Chan, A.S., Lam, P.W., Tse, C.W., Dunlop, M.G., Wyllie, A.H., et al. Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomes. Oncogene 20 (2001), 4871–4876.
17. Chu, J., Sadeghi, S., Raymond, A., Jackman, S.D., Nip, K.M., Mar, R., Mohamadi, H., Butterfield, Y.S., Robertson, A.G., Birol, I., BioBloom tools: fast, accurate and memory-efficient host species sequence screening using bloom filters. Bioinformatics 30 (2014), 3402–3404.
18. Cibulskis, K., McKenna, A., Fennell, T., Banks, E., DePristo, M., Getz, G., ContEst: estimating cross-contamination of human samples in next-generation sequencing data. Bioinformatics 27 (2011), 2601–2602.
19. Cibulskis, K., Lawrence, M.S., Carter, S.L., Sivachenko, A., Jaffe, D., Sougnez, C., Gabriel, S., Meyerson, M., Lander, E.S., Getz, G., Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31 (2013), 213–219.
20. Costello, M., Pugh, T.J., Fennell, T.J., Stewart, C., Lichtenstein, L., Meldrim, J.C., Fostel, J.L., Friedrich, D.C., Perrin, D., Dionne, D., et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res., 41, 2013, e67.
21. Cristescu, R., Lee, J., Nebozhyn, M., Kim, K.M., Ting, J.C., Wong, S.S., Liu, J., Yue, Y.G., Wang, J., Yu, K., et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat. Med. 21 (2015), 449–456.
22. Daily, K., Ho Sui, S.J., Schriml, L.M., Dexheimer, P.J., Salomonis, N., Schroll, R., Bush, S., Keddache, M., Mayhew, C., Lotia, S., et al. Molecular, phenotypic, and sample-associated data to describe pluripotent stem cell lines and derivatives. Sci. Data, 4, 2017, 170030.
23. Davoli, T., Uno, H., Wooten, E.C., Elledge, S.J., Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science, 355, 2017, 10.1126/science.aaf8399.
24. Derks, S., Liao, X., Chiaravalli, A.M., Xu, X., Camargo, M.C., Solcia, E., Sessa, F., Fleitas, T., Freeman, G.J., Rodig, S.J., et al. Abundant PD-L1 expression in Epstein-Barr virus-infected gastric cancers. Oncotarget 7 (2016), 32925–32932.
25. Dienstmann, R., Vermeulen, L., Guinney, J., Kopetz, S., Tejpar, S., Tabernero, J., Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer. Nat. Rev. Cancer 17 (2017), 79–92.
26. Dulak, A.M., Schumacher, S.E., van Lieshout, J., Imamura, Y., Fox, C., Shim, B., Ramos, A.H., Saksena, G., Baca, S.C., Baselga, J., et al. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis. Cancer Res. 72 (2012), 4383–4393.
27. Dulak, A.M., Stojanov, P., Peng, S., Lawrence, M.S., Fox, C., Stewart, C., Bandla, S., Imamura, Y., Schumacher, S.E., Shefler, E., et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet. 45 (2013), 478–486.
28. Ebert, M.P., Tanzer, M., Balluff, B., Burgermeister, E., Kretzschmar, A.K., Hughes, D.J., Tetzner, R., Lofton-Day, C., Rosenberg, R., Reinacher-Schick, A.C., et al. TFAP2E-DKK4 and chemoresistance in colorectal cancer. N. Engl. J. Med. 366 (2012), 44–53.
29. Fang, M., Hutchinson, L., Deng, A., Green, M.R., Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma. Proc. Natl. Acad. Sci. USA 113 (2016), 1250–1255.
30. Forbes, S.A., Bindal, N., Bamford, S., Cole, C., Kok, C.Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39 (2011), D945–D950.
31. Ganem, N.J., Storchova, Z., Pellman, D., Tetraploidy, aneuploidy and cancer. Curr. Opin. Genet. Dev. 17 (2007), 157–162.
32. GTEx Consortium; Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group; Statistical Methods groups—Analysis Working Group; Enhancing GTEx (eGTEx) groups; NIH Common Fund; NIH/NCI; NIH/NHGRI; NIH/NIMH; NIH/NIDA, Biospecimen Collection Source Site—NDRI, et al. Genetic effects on gene expression across human tissues. Nature 550 (2017), 204–213.
33. Guinney, J., Dienstmann, R., Wang, X., de Reynies, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. The consensus molecular subtypes of colorectal cancer. Nat. Med. 21 (2015), 1350–1356.
34. Guo, Z., Kozlov, S., Lavin, M.F., Person, M.D., Paull, T.T., ATM activation by oxidative stress. Science 330 (2010), 517–521.
35. Herman, J.G., Umar, A., Polyak, K., Graff, J.R., Ahuja, N., Issa, J.P., Markowitz, S., Willson, J.K., Hamilton, S.R., Kinzler, K.W., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 95 (1998), 6870–6875.
36. Hinoue, T., Weisenberger, D.J., Pan, F., Campan, M., Kim, M., Young, J., Whitehall, V.L., Leggett, B.A., Laird, P.W., Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling. PLoS One, 4, 2009, e8357.
37. Hoadley, K.A., Yau, C., Wolf, D.M., Cherniack, A.D., Tamborero, D., Ng, S., Leiserson, M.D., Niu, B., McLellan, M.D., Uzunangelov, V., et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158 (2014), 929–944.
38. Hoadley, K.A., Yau, C., Hinoue, T., Wolf, D.M., Lazar, A.J., Drill, E., Shen, R., Taylor, A.M., Cherniack, A.D., Thorsson, V., et al. (2018). Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell, https://doi.org/10.1016/j.cell.2018.03.022.
39. International Agency for Research on Cancer, WHO Classification of Tumours of the Digestive System. Fourth Edition, 2010, WHO.
40. Isella, C., Terrasi, A., Bellomo, S.E., Petti, C., Galatola, G., Muratore, A., Mellano, A., Senetta, R., Cassenti, A., Sonetto, C., et al. Stromal contribution to the colorectal cancer transcriptome. Nat. Genet. 47 (2015), 312–319.
41. Janjigian, Y.Y., Sanchez-Vega, F., Jonsson, P., Chatila, W.K., Hechtman, J.F., Ku, G.Y., Riches, J.C., Tuvy, Y., Kundra, R., Bouvier, N., et al. Genetic predictors of response to systemic therapy in esophagogastric cancer. Cancer Discov. 8 (2018), 49–58.
42. Javier, B.M., Yaeger, R., Wang, L., Sanchez-Vega, F., Zehir, A., Middha, S., Sadowska, J., Vakiani, E., Shia, J., Klimstra, D., et al. Recurrent, truncating SOX9 mutations are associated with SOX9 overexpression, KRAS mutation, and TP53 wild type status in colorectal carcinoma. Oncotarget 7 (2016), 50875–50882.
43. Jin, Z., Yoon, H.H., The promise of PD-1 inhibitors in gastro-esophageal cancers: microsatellite instability vs. PD-L1. J. Gastrointest. Oncol. 7 (2016), 771–788.
44. Kim, J., Fox, C., Peng, S., Pusung, M., Pectasides, E., Matthee, E., Hong, Y.S., Do, I.G., Jang, J., Thorner, A.R., et al. Preexisting oncogenic events impact trastuzumab sensitivity in ERBB2-amplified gastroesophageal adenocarcinoma. J. Clin. Invest. 124 (2014), 5145–5158.
45. Kim, J., Mouw, K.W., Polak, P., Braunstein, L.Z., Kamburov, A., Tiao, G., Kwiatkowski, D.J., Rosenberg, J.E., Van Allen, E.M., D'Andrea, A.D., et al. Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors. Nat. Genet. 48 (2016), 600–606.
46. Koh, J., Ock, C.Y., Kim, J.W., Nam, S.K., Kwak, Y., Yun, S., Ahn, S.H., Park, D.J., Kim, H.H., Kim, W.H., et al. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients. Oncotarget 8 (2017), 26356–26367.
47. Korn, J.M., Kuruvilla, F.G., McCarroll, S.A., Wysoker, A., Nemesh, J., Cawley, S., Hubbell, E., Veitch, J., Collins, P.J., Darvishi, K., et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 40 (2008), 1253–1260.
48. Kostic, A.D., Ojesina, A.I., Pedamallu, C.S., Jung, J., Verhaak, R.G., Getz, G., Meyerson, M., PathSeq: software to identify or discover microbes by deep sequencing of human tissue. Nat. Biotechnol. 29 (2011), 393–396.
49. Lawrence, M.S., Stojanov, P., Mermel, C.H., Robinson, J.T., Garraway, L.A., Golub, T.R., Meyerson, M., Gabriel, S.B., Lander, E.S., Getz, G., Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505 (2014), 495–501.
50. Le, D.T., Durham, J.N., Smith, K.N., Wang, H., Bartlett, B.R., Aulakh, L.K., Lu, S., Kemberling, H., Wilt, C., Luber, B.S., et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357 (2017), 409–413.
51. Leffers, H., Dejgaard, K., Celis, J.E., Characterisation of two major cellular poly(rC)-binding human proteins, each containing three K-homologous (KH) domains. Eur. J. Biochem. 230 (1995), 447–453.
52. Leung, S.Y., Yuen, S.T., Chung, L.P., Chu, K.M., Chan, A.S., Ho, J.C., hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res. 59 (1999), 159–164.
53. Li, B., Dewey, C.N., RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics, 12, 2011, 323.
54. Li, M., Fang, X., Baker, D.J., Guo, L., Gao, X., Wei, Z., Han, S., van Deursen, J.M., Zhang, P., The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc. Natl. Acad. Sci. USA 107 (2010), 14188–14193.
55. Ljunggren, H.G., Malmberg, K.J., Prospects for the use of NK cells in immunotherapy of human cancer. Nat. Rev. Immunol. 7 (2007), 329–339.
56. Lynch, H.T., Snyder, C.L., Shaw, T.G., Heinen, C.D., Hitchins, M.P., Milestones of Lynch syndrome: 1895–2015. Nat. Rev. Cancer 15 (2015), 181–194.
57. Malta, T.M., Sokolov, A.,Gentles, A.J., Burzykowski, T.,Poisson, L., Weinstein, J.N., Kamińska, B., Huelsken,J., Omberg,L., Gevaert, O. (2018). Machine learning identifiesstemness features associated with oncogenic dedifferentiation. Cell, https://doi.org/10.1016/j.cell.2018.03.034.
58. Matsusaka, K., Kaneda, A., Nagae, G., Ushiku, T., Kikuchi, Y., Hino, R., Uozaki, H., Seto, Y., Takada, K., Aburatani, H., et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. 71 (2011), 7187–7197.
59. McCarroll, S.A., Kuruvilla, F.G., Korn, J.M., Cawley, S., Nemesh, J., Wysoker, A., Shapero, M.H., de Bakker, P.I., Maller, J.B., Kirby, A., et al. Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat. Genet. 40 (2008), 1166–1174.
60. McConnell, B.B., Kim, S.S., Yu, K., Ghaleb, A.M., Takeda, N., Manabe, I., Nusrat, A., Nagai, R., Yang, V.W., Kruppel-like factor 5 is important for maintenance of crypt architecture and barrier function in mouse intestine. Gastroenterology 141 (2011), 1302–1313 1313.e1–6.
61. Mermel, C.H., Schumacher, S.E., Hill, B., Meyerson, M.L., Beroukhim, R., Getz, G., GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol., 12, 2011, R41.
62. Mishra, L., Shetty, K., Tang, Y., Stuart, A., Byers, S.W., The role of TGF-beta and Wnt signaling in gastrointestinal stem cells and cancer. Oncogene 24 (2005), 5775–5789.
63. Moons, L.M., Bax, D.A., Kuipers, E.J., Van Dekken, H., Haringsma, J., Van Vliet, A.H., Siersema, P.D., Kusters, J.G., The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. J. Clin. Pathol. 57 (2004), 1063–1068.
64. Muro, K., Chung, H.C., Shankaran, V., Geva, R., Catenacci, D., Gupta, S., Eder, J.P., Golan, T., Le, D.T., Burtness, B., et al. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Lancet Oncol. 17 (2016), 717–726.
65. Nandan, M.O., Ghaleb, A.M., Liu, Y., Bialkowska, A.B., McConnell, B.B., Shroyer, K.R., Robine, S., Yang, V.W., Inducible intestine-specific deletion of Kruppel-like factor 5 is characterized by a regenerative response in adult mouse colon. Dev. Biol. 387 (2014), 191–202.
66. Noah, T.K., Donahue, B., Shroyer, N.F., Intestinal development and differentiation. Exp. Cell Res. 317 (2011), 2702–2710.
67. Olshen, A.B., Venkatraman, E.S., Lucito, R., Wigler, M., Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 5 (2004), 557–572.
68. Palles, C., Cazier, J.B., Howarth, K.M., Domingo, E., Jones, A.M., Broderick, P., Kemp, Z., Spain, S.L., Guarino, E., Salguero, I., et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat. Genet. 45 (2013), 136–144.
69. Phipps, A.I., Passarelli, M.N., Chan, A.T., Harrison, T.A., Jeon, J., Hutter, C.M., Berndt, S.I., Brenner, H., Caan, B.J., Campbell, P.T., et al. Common genetic variation and survival after colorectal cancer diagnosis: a genome-wide analysis. Carcinogenesis 37 (2016), 87–95.
70. Ramos, A.H., Lichtenstein, L., Gupta, M., Lawrence, M.S., Pugh, T.J., Saksena, G., Meyerson, M., Getz, G., Oncotator: cancer variant annotation tool. Hum. Mutat. 36 (2015), E2423–E2429.
71. Ratan, A., Olson, T.L., Loughran, T.P. Jr., Miller, W., Identification of indels in next-generation sequencing data. BMC Bioinformatics, 16, 2015, 42.
72. Reed, K.R., Korobko, I.V., Ninkina, N., Korobko, E.V., Hopkins, B.R., Platt, J.L., Buchman, V., Clarke, A.R., Hunk/Mak-v is a negative regulator of intestinal cell proliferation. BMC Cancer, 15, 2015, 110.
73. Reich, M., Liefeld, T., Gould, J., Lerner, J., Tamayo, P., Mesirov, J.P., GenePattern 2.0. Nat. Genet. 38 (2006), 500–501.
74. Roepman, P., Schlicker, A., Tabernero, J., Majewski, I., Tian, S., Moreno, V., Snel, M.H., Chresta, C.M., Rosenberg, R., Nitsche, U., et al. Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition. Int. J. Cancer 134 (2014), 552–562.
75. Salari, K., Spulak, M.E., Cuff, J., Forster, A.D., Giacomini, C.P., Huang, S., Ko, M.E., Lin, A.Y., van de Rijn, M., Pollack, J.R., CDX2 is an amplified lineage-survival oncogene in colorectal cancer. Proc. Natl. Acad. Sci. USA 109 (2012), E3196–E3205.
76. Salomonis, N., Dexheimer, P.J., Omberg, L., Schroll, R., Bush, S., Huo, J., Schriml, L., Ho Sui, S., Keddache, M., Mayhew, C., et al. Integrated genomic analysis of diverse induced pluripotent stem cells from the Progenitor Cell Biology Consortium. Stem Cell Reports 7 (2016), 110–125.
77. Sartore-Bianchi, A., Trusolino, L., Martino, C., Bencardino, K., Lonardi, S., Bergamo, F., Zagonel, V., Leone, F., Depetris, I., Martinelli, E., et al. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. Lancet Oncol. 17 (2016), 738–746.
78. Schepers, A., Clevers, H., Wnt signaling, stem cells, and cancer of the gastrointestinal tract. Cold Spring Harb. Perspect. Biol., 4, 2012, a007989.
79. Secrier, M., Li, X., de Silva, N., Eldridge, M.D., Contino, G., Bornschein, J., MacRae, S., Grehan, N., O'Donovan, M., Miremadi, A., et al. Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance. Nat. Genet. 48 (2016), 1131–1141.
80. Sheltzer, J.M., Blank, H.M., Pfau, S.J., Tange, Y., George, B.M., Humpton, T.J., Brito, I.L., Hiraoka, Y., Niwa, O., Amon, A., Aneuploidy drives genomic instability in yeast. Science 333 (2011), 1026–1030.
81. Sheltzer, J.M., Ko, J.H., Replogle, J.M., Habibe Burgos, N.C., Chung, E.S., Meehl, C.M., Sayles, N.M., Passerini, V., Storchova, Z., Amon, A., Single-chromosome gains commonly function as tumor suppressors. Cancer Cell 31 (2017), 240–255.
82. Sherwood, R.I., Chen, T.Y., Melton, D.A., Transcriptional dynamics of endodermal organ formation. Dev. Dyn. 238 (2009), 29–42.
83. Sia, E.A., Kokoska, R.J., Dominska, M., Greenwell, P., Petes, T.D., Microsatellite instability in yeast: dependence on repeat unit size and DNA mismatch repair genes. Mol. Cell Biol. 17 (1997), 2851–2858.
84. Sokolov, A., Paull, E.O., Stuart, J.M., One-class detection of cell States in tumor subtypes. Pac. Symp. Biocomput. 21 (2016), 405–416.
85. Tan, I.B., Ivanova, T., Lim, K.H., Ong, C.W., Deng, N., Lee, J., Tan, S.H., Wu, J., Lee, M.H., Ooi, C.H., et al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 141 (2011), 476–485 485.e1–11.
86. Thompson, S.L., Compton, D.A., Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J. Cell Biol. 188 (2010), 369–381.
87. Thorsson, V., Gibbs, D.L., Brown, S.D., Wolf, D., Bortone, D.S., Ou Yang, T.-H., Porta Pardo, E., Gao, G., Eddy, J.A., Plaisier, C.L., et al. (2018). The ilmmune landscape of cancer. Immunity, https://doi.org/10.1016/j.immuni.2018.03.023.
88. Torre, L.A., Siegel, R.L., Ward, E.M., Jemal, A., Global cancer incidence and mortality rates and trends–an update. Cancer Epidemiol. Biomarkers Prev. 25 (2016), 16–27.
89. Torres, E.M., Sokolsky, T., Tucker, C.M., Chan, L.Y., Boselli, M., Dunham, M.J., Amon, A., Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317 (2007), 916–924.
90. Tripathi, V., Sixt, K.M., Gao, S., Xu, X., Huang, J., Weigert, R., Zhou, M., Zhang, Y.E., Direct regulation of alternative splicing by SMAD3 through PCBP1 is essential to the tumor-promoting role of TGF-beta. Mol. Cell, 64, 2016, 1010.
91. Wagner, J.A., Rosario, M., Romee, R., Berrien-Elliott, M.M., Schneider, S.E., Leong, J.W., Sullivan, R.P., Jewell, B.A., Becker-Hapak, M., Schappe, T., et al. CD56bright NK cells exhibit potent antitumor responses following IL-15 priming. J. Clin. Invest. 127 (2017), 4042–4058.
92. Wang, K., Singh, D., Zeng, Z., Coleman, S.J., Huang, Y., Savich, G.L., He, X., Mieczkowski, P., Grimm, S.A., Perou, C.M., et al. MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res., 38, 2010, e178.
93. Wang, K., Yuen, S.T., Xu, J., Lee, S.P., Yan, H.H., Shi, S.T., Siu, H.C., Deng, S., Chu, K.M., Law, S., et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46 (2014), 573–582.
94. Weisenberger, D.J., Siegmund, K.D., Campan, M., Young, J., Long, T.I., Faasse, M.A., Kang, G.H., Widschwendter, M., Weener, D., Buchanan, D., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat. Genet. 38 (2006), 787–793.
95. Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D.J., Campan, M., Young, J., Jacobs, I., et al. Epigenetic stem cell signature in cancer. Nat. Genet. 39 (2007), 157–158.
96. Williams, B.R., Prabhu, V.R., Hunter, K.E., Glazier, C.M., Whittaker, C.A., Housman, D.E., Amon, A., Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322 (2008), 703–709.
97. Zhou, Q., Talvinen, K., Sundstrom, J., Elzagheid, A., Pospiech, H., Syvaoja, J.E., Collan, Y., Mutations/polymorphisms in the 55 kDa subunit of DNA polymerase epsilon in human colorectal cancer. Cancer Genomics Proteomics 6 (2009), 297–304.